Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Registration Number : 218MF10147
Registrant's Address : 23, rue Bossuet Z. I. de la Vigne aux Loups F-91160 LONGJUMEAU France
Initial Date of Registration : 2006-01-31
Latest Date of Registration : 2006-10-20
A Mepenzolate Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mepenzolate Bromide, including repackagers and relabelers. The FDA regulates Mepenzolate Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mepenzolate Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mepenzolate Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mepenzolate Bromide supplier is an individual or a company that provides Mepenzolate Bromide active pharmaceutical ingredient (API) or Mepenzolate Bromide finished formulations upon request. The Mepenzolate Bromide suppliers may include Mepenzolate Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Mepenzolate Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mepenzolate Bromide Drug Master File in Japan (Mepenzolate Bromide JDMF) empowers Mepenzolate Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mepenzolate Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Mepenzolate Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mepenzolate Bromide suppliers with JDMF on PharmaCompass.
We have 1 companies offering Mepenzolate Bromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
